In Brief: Novartis
This article was originally published in The Tan Sheet
Executive Summary
Novartis: Negotiating with FDA on Habitrol nicotine patch labeling revisions to include combination treatment with an undisclosed prescription product; Glaxo Wellcome's Zyban (bupropion), also indicated for smoking cessation, is a likely candidate. Novartis does not plan to pursue an Rx-to-OTC switch of Habitrol...